The FDA approved lurbinectedin (Zepzelca) for the treatment of adult patients with metastatic small cell lung cancer with disease progression, following platinum-based chemotherapy.
By ONN Staff
Advertisement
Articles by By ONN Staff
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
3
How Oncology Nurses Can Overcome Common Barriers to Research
4
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
5